glp-1 degradation metabolite GLP-1(9–36) is a systemic inhibitor of mouse and human pancreatic islet glucagon secretion | Diabetologia Understanding GLP-1 receptor agonists and

Even FDA-approved medicines have side effects, sometimes serious ones, he pointed out

Density maps for ghrelin and GLP-1 overlap in reward regions For ghrelin, peak coordinates from 18 different contrasts had a positive association with reward-related brain responses (Figure 2, Panel a), whereas coordinates from only 7 different contrasts had a negative association

This is documented in UK product information for these medicines

Adherence to dosing schedules directly impacts effectiveness

in the US, EU and UK it is not approved for human use and is sold strictly as a research chemical [6]

Rigorous, large-scale studies are needed to draw definitive conclusions about the link between GLP-1 and hair loss